Inventor · disambiguated record
Michael H. Davidson
Also filed as: DAVIDSON MICHAEL · DAVIDSON MICHAEL H · DAVIDSON MICHAEL HARVEY
10 granted patents·17 pending applications·105 citations·filing 1992–2025
87Inventor score
Files withOMTHERA PHARMACEUTICALS INC7NOVO NORDISK AS4SONOGENE LLC3DAVIDSON MICHAEL H2MINERVA NEUROSCIENCES INC2
Top patents by PatentIndex Score
27 records- 0188US9050308B2DPA-enriched compositions of omega-3 polyunsaturated fatty acids in free acid formOMTHERA PHARMACEUTICALS INC·Filed 2013·Granted Jun 9, 2015·19 cites·11 claims
- 0282US9050309B2DPA-enriched compositions of omega-3 polyunsaturated fatty acids in free acid formOMTHERA PHARMACEUTICALS INC·Filed 2013·Granted Jun 9, 2015·7 cites·11 claims
- 0379US7211248B2Enhancement of transfection of DNA into the liverSONOGENE L L C·Filed 2002·Granted May 1, 2007·13 cites·14 claims
- 0476US11384143B2Methods for treating IL-6 mediated inflammation without immunosuppressionNOVO NORDISK AS·Filed 2019·Granted Jul 12, 2022·2 cites·12 claims
- 0572US2023090473A1Methods for treating il-6 mediated inflammation without immunosuppressionNOVO NORDISK AS·Filed 2022·Application pending·0 cites
- 0669US2022227856A1Methods for treating il-6 mediated inflammation without immunosuppressionNOVO NORDISK AS·Filed 2022·Application pending·0 cites
- 0767US2023190726A1Compositions and methods for treating negative symptoms in non-schizophrenic patientsMINERVA NEUROSCIENCES INC·Filed 2022·Application pending·0 cites
- 0866US9492545B2Compositions of statins and omega-3 fatty acidsOMTHERA PHARMACEUTICALS INC·Filed 2013·Granted Nov 15, 2016·1 cites·32 claims
- 0961US2025170128A1Obicetrapib and SGLT2 Inhibitor CombinationNEWAMSTERDAM PHARMA B V DUTCH CHAMBER OF COMMERCE NO 5597 1946·Filed 2022·Application pending·0 cites
- 1059US2007196283A1Composition for transfection of DNA into the liverSONOGENE LLC·Filed 2007·Application pending·0 cites
- 1158US2023041138A1Treatment of his hyporespondersNEWAMSTERDAM PHARMA B V DUTCH REGISTRATION NO 55971946·Filed 2022·Application pending·0 cites
- 1258US2019241650A1Methods for treating il-6 mediated inflammation without immunosuppressionCORVIDIA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1357US2024189311A1Combination Therapy of Obicetrapib and Ezetimibe for Use in Statin Intolerant Patients Suffering from Hyperlipidemia or Mixed DyslipidaemiaNEWAMSTERDAM PHARMA B V·Filed 2022·Application pending·0 cites
- 1456US2019029985A1Dpa-enriched compositions of omega-3 polyunsaturated fatty acids in free acid formOMTHERA PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 1555US2019216793A1Compositions and methods for treating negative symptoms in non-schizophrenic patientsMINERVA NEUROSCIENCES INC·Filed 2017·Application pending·0 cites
- 1650US10117844B2DPA-enriched compositions of omega-3 polyunsaturated fatty acids in free acid formOMTHERA PHARMACEUTICALS INC·Filed 2015·Granted Nov 6, 2018·0 cites·43 claims
- 1750US2004001874A1Safe and effective nutritional supplement formulations and associated regimens adapted to prevent and/or treat targeted diseases or medical or health conditions, and related methodsVITAL LIVING INC·Filed 2003·Application pending·0 cites
- 1850US2023287105A1Methods for treating cardiovascular diseaseNOVO NORDISK AS·Filed 2021·Application pending·0 cites
- 1949US10086082B2Plant steroids and uses thereofDAVIDSON MICHAEL·Filed 2012·Granted Oct 2, 2018·0 cites·11 claims
- 2049US2016124003A1Methods and compositions for treating or preventing attention deficit hyperactivity disorderOMTHERA PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 2148US9101745B2Sonochemical induction of ABCA1 expression and compositions thereforSONOGENE LLC·Filed 2013·Granted Aug 11, 2015·0 cites·14 claims
- 2248US5279540AMethod for reducing the risk of atherosclerosisDAVIDSON MICHAEL H·Filed 1992·Granted Jan 18, 1994·63 cites·15 claims
- 2345US2014316003A1Methods and compositions for treating or preventing attention deficit hyperactivity disorderOMTHERA PHARMACEUTICALS INC·Filed 2012·Application pending·0 cites
- 2445US2025186442A1Obicetrapib and Ezetimibe Combination Treatment and Fixed Dose Pharmaceutical CompositionsNEWAMSTERDAM PHARMA B V·Filed 2025·Application pending·0 cites
- 2544US2019083632A1Plant steroids and uses thereofDAVIDSON LOPEZ LLC·Filed 2018·Application pending·0 cites
- 2643US9393328B2Sonochemical induction of ABCA1 expression and compositions thereforSONOGENE LLC·Filed 2015·Granted Jul 19, 2016·0 cites·24 claims
- 2735US2013095179A1Methods and compositions for treating, reversing, inhibiting or preventing resistance to antiplatelet therapyDAVIDSON MICHAEL H·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael H. Davidson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →